Investment Partners, Ltd. Gsk PLC Transaction History

Investment Partners, Ltd.

$239 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$42.05 - $47.77 $883 - $1,003	21 Added 0.36%	5,825 $254,000
Q1 2022 Apr 22, 2022	SELL	$40.23 - $47.74 $8,287 - $9,834	-206 Reduced 3.43%	5,804 $253,000
Q4 2021 Feb 04, 2022	BUY	$38.88 - $45.31 $894 - $1,042	23 Added 0.38%	6,010 $265,000
Q3 2021 Oct 13, 2021	BUY	$38.79 - $43.16 $930 - $1,035	24 Added 0.4%	5,987 $229,000
Q2 2021 Jul 15, 2021	BUY	$36.52 - $41.46 $217,768 - $247,225	5,963 New	5,963 $237,000
Q3 2020 Nov 09, 2020	SELL	$38.11 - $42.99 $297,943 - $336,095	-7,818 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$37.87 - $43.58 $50,442 - $58,048	1,332 Added 20.54%	7,818 $319,000
Q1 2020 Apr 29, 2020	SELL	$32.47 - $48.83 $9,124 - $13,721	-281 Reduced 4.15%	6,486 $246,000
Q4 2019 Jan 31, 2020	SELL	$42.0 - $48.25 $6,888 - $7,913	-164 Reduced 2.37%	6,767 $318,000
Q3 2019 Oct 17, 2019	BUY	$40.46 - $43.52 $2,913 - $3,133	72 Added 1.05%	6,931 $296,000
Q2 2019 Jul 30, 2019	SELL	$39.4 - $42.7 $18,399 - $19,940	-467 Reduced 6.37%	6,859 $275,000
Q1 2019 May 03, 2019	BUY	$38.57 - $42.69 $10,876 - $12,038	282 Added 4.0%	7,326 $306,000
Q4 2018 Jan 15, 2019	BUY	$37.8 - $42.69 $1,171 - $1,323	31 Added 0.44%	7,044 $269,000
Q3 2018 Oct 29, 2018	BUY	$39.75 - $42.69 $278,766 - $299,384	7,013 New	7,013 $231,000
Q3 2018 Oct 25, 2018	SELL	$39.75 - $42.69 $281,032 - $301,818	-7,070 Closed	0 $0
Q2 2018 Jul 25, 2018	SELL	$39.61 - $42.76 $93,638 - $101,084	-2,364 Reduced 25.06%	7,070 $285,000
Q1 2018 May 03, 2018	BUY	$36.18 - $40.15 $2,460 - $2,730	68 Added 0.73%	9,434 $369,000
Q4 2017 Jan 31, 2018	SELL	$35.34 - $41.9 $212 - $251	-6 Reduced 0.06%	9,366 $332,000
Q3 2017 Oct 30, 2017	BUY	$39.44 - $41.55 $369,631 - $389,406	9,372	9,372 $381,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Investment Partners, Ltd. with notifications on news.

Account